Abstract
The mixed radiation field produced during BNCT comprises radiations with different linear energy transfer (LET) characteristics and different efficacies in biological systems (relative biological effectiveness: RBE). The four major components of the BNCT radiation dose are: boron neutron capture (BNC) dose, gamma dose (originating primarily from neutron capture in hydrogen), fast neutron dose, and the nitrogen neutron capture (NNC) dose. Because of different attenuation of gamma rays and neutrons with various energies, the relative contributions of these components to the total dose vary with depth in tissues. In addition, the short range of BNC reaction products makes the 10B microdistribution particularly important and a compound biological effectiveness (CBE) factor must be used to express the BNC dose in photon gray-equivalent (Gy-Eq) units.1 Evaluation of the radiation doses delivered during BNCT combines data on spatial distribution of gamma and neutron fluxes, the 10B concentration and RBE/CBE factors. We report the radiation doses delivered to the tumors (post-operative contrast enhancing volumes), target volumes (tumor + a 2-cm margin), and different parts of the brains of 41 glioblastoma multiforme (GBM) patients treated with BNCT at the Brookhaven Medical Research Reactor (BMRR).2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.A. Coderre, M.S. Makar, P.L. Micca, M.M. Nawrocky, H.B. Liu, D.D. Joel, D.N. Slatkin, and H.I. Amols, Derivations of relative biological effectiveness for the high-LET radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo. Int. J. Radiat. Oncol. Biol. Phys. 27:1121–1129, 1993.
A.Z. Diaz, A.D. Chanana, J. Capala, M. Chadha, J.A. Coderre, E.H. Elowitz, J. Iwai, D.D. Joel, H.B. Liu, R. Ma, N. Pendzick, N.S. Peress, M.S. Shady, D.N. Slatkin, G.W. Tyson, and L. Wielopolski, Boron neutron capture therapy for glioblastoma multiforme: results from the initial phase I/II dose escalation studies, in “Frontiers in Neutron Capture Therapy,” M.F. Hawthorne, K. Shelly, R.W. Wiersema, eds., Kluwer Academic/Plenum Publishers, New York, 2001, pp. 61–72.
H.B. Liu, D.D. Greenberg, J. Capala, and F.J. Wheeler, An improved neutron collimator for brain tumor irradiations in clinical boron neutron capture therapy. Med. Phys. 23:2051–2060, 1996.
J. Capala, M. Chadha, J.A. Coderre, A.Z. Diaz, H.B. Liu, R. Ma, D.E. Wessol, F.J. Wheeler, L. Wielopolski, and A.D. Chanana, Boron Neutron therapy of glioblastoma multiforme: Treatment planning implementation in dose escalation trials. Int. J. Radiat. Oncol. Biol. Phys., 1998 (submitted).
J. Capala, A.Z. Diaz, R. Ma, and A.D. Chanana, Optimization of double-field boron neutron capture therapy for unilateral, supratentorial glioblastoma multiforme, Program and Abstracts of the Eighth International Symposium on NCT for Cancer, La Jolla, CA, 1998, p. 134.
D.W Nigg, F.J. Wheeler, D.E. Wessol, J. Capala, and M. Chadha, Computational dosimetry and treatment planning for boron neutron capture therapy. J. Neuro-Oncol. 33:93–104, 1997.
J.A. Coderre and G.M. Morris, Review article: The radiation biology of boron neutron capture therapy. Rad. Res., 151, 1–18 (1998).
D.R. Smith, S. Chandra, J.A. Coderre, D.D. Joel, D.N. Slatkin, A.D. Chanana, E.H. Elowitz, M.M. Nawrocki, P.L. Micca, and G.M. Morrison, Ion microscopy imaging of boron from p- boronophenylalanine (BPA) in surgically acquired samples of human tumor tissue, in “Frontiers in Neutron Capture Therapy,” M.F. Hawthorne, K. Shelly, R.W. Wiersema, eds., Kluwer Academic/Plenum Publishers, New York, 2001, pp. 899–903.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Capala, J., Coderre, J.A., Diaz, A.Z., Ma, R., Chanana, A.D. (2001). Nominal Effective Radiation Doses Delivered to the Tumor and Different Parts of the Normal Brain During BNCT for Glioblastoma Multiforme. In: Hawthorne, M.F., Shelly, K., Wiersema, R.J. (eds) Frontiers in Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1285-1_81
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1285-1_81
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5478-9
Online ISBN: 978-1-4615-1285-1
eBook Packages: Springer Book Archive